Navigation Links
Organovo Reports 2012 Financial Results
Date:3/18/2013

SAN DIEGO, March 18, 2013 /PRNewswire/ -- Organovo Holdings, Inc. (OTCQX: ONVO) ("Organovo"), a three-dimensional biology company focused on delivering breakthrough 3D bioprinting technology, has reported on its financial results for the year ended December 31, 2012.  The Company also reported on its corporate highlights during fiscal 2012.

2012 Corporate Highlights

  • Closed  $24.6 million in equity financings associated with the Company's go-public reverse merger;
  • Recorded $1.2 million in revenue, representing a twenty percent (20%) increase over the prior year
  • Received multiple issued patents, including the Company's first assigned patent, and licensed an additional issued patent
  • Formed a partnership with Autodesk Research to develop 3D bioprinting software
  • Joined QX tier of the OTC Markets
  • Moved to a new larger research and headquarters facility
  • Expanded executive management with the addition of Dr. Eric David as Chief Strategic Officer and Michael Renard as Chief Commercial Officer
  • Appointed an additional independent director to serve as Audit Committee Chairman
  • Reduced its warrant liability by $23.3 million
  • Named in  TR50Technology Review's annual list of the world's most innovative technology companies
  • Featured in Wall Street Journal
  • "Organovo successfully went public, grew substantially, and raised significant financing in 2012," stated Keith Murphy, chief executive officer of Organovo. "We continue to attract great partners and see tremendous scientific results from our bioprinting efforts.  We look forward to continued success in 2013 as we seek to continue to provide long-term shareholder value."

    Financial ResultsRevenues
    2012 total revenues of $1.2 million, representing an inc
    '/>"/>

    SOURCE Organovo Holdings, Inc.
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8

    Related medicine technology :

    1. Organovo Holdings, Inc. announces redemption of 2.9 million outstanding warrants
    2. Organovo and OHSU Knight Cancer Institute Announce Collaboration in Cancer Research
    3. Market Boosted by Strong Tech Earnings: Bank of America Corp., MAP Pharmaceuticals Inc., Swingplane Ventures Inc., World Moto, Inc., Organovo Holdings, Inc.
    4. Organovo Reports Q2 2012 Financial Results, Provides Business Update
    5. Organovo, Inc. Investor Presentation Now Available for On-demand Viewing at RetailInvestorConferences.com
    6. Organovo Announces Two Issued Patents, First Company Patent and Key Founder Patent
    7. Organovo Holdings Appoints James T. Glover to Board of Directors
    8. China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2012
    9. Orexigen Therapeutics Reports Financial Results for the Fourth Quarter and Year Ended December 31, 2012
    10. Isis Pharmaceuticals Reports Clinical Data Showing Blunting of Severe Increases in CRP Following Endotoxin Challenge With ISIS-CRP Rx
    11. Addus HomeCare Reports Fourth Quarter 2012 Results Completes Sale of Home Health Assets
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:12/24/2014)... BUFFALO, N.Y. , Dec. 24, 2014 ... been dosed with KX2-361 at Roswell Park Cancer Institute. ... a small molecule drug that has shown potent inhibitory ... lines, including those that are resistant to Temozolomide (T98G), ... malignant glioma. In a well-established brain tumor mouse model, ...
    (Date:12/24/2014)... , Dec. 24, 2014  The International Trade Commission (ITC) ... (RMD) against BMC Medical. In a notice issued on December ... that ResMed,s patent on its humidifier was invalid. ... "monumental win". "We are very excited with the ITC,s decision ... that we have taken since the very beginning on the ...
    (Date:12/24/2014)... Dec. 24, 2014  Diplomat Pharmacy, Inc. (NYSE: ... is proud to announce Jennifer Hagerman , Pharm.D., ... will take office as the president of the Michigan ... ceremony will take place Feb. 28, 2015, at the ... at the Renaissance Center in Detroit, Michigan ...
    Breaking Medicine Technology:Kinex Pharmaceuticals Announces First Patient Dosed with KX2-361 in a Phase 1 Clinical Study 2Kinex Pharmaceuticals Announces First Patient Dosed with KX2-361 in a Phase 1 Clinical Study 3ITC Final Decision Goes Against ResMed (RMD) Monumental Win for 3B/BMC 2Diplomat's senior director of education and quality to be inducted as 2015 president of the Michigan Pharmacists Association 2Diplomat's senior director of education and quality to be inducted as 2015 president of the Michigan Pharmacists Association 3
    ... the leaders of "America,s pastime," a free open-source screen-reading software ... of Camp Abilities have in common? All have taken successful ... who are blind or visually impaired, which is why they ... today by the American Foundation for the Blind (AFB). ...
    ... Pharmaceutical Inc., a biotechnology company focused on developing ... announced that the European Medicines Agency (EMA) has ... the treatment of hereditary inclusion body myopathy (HIBM) ... mucopolysaccharidosis type 7 (MPS 7).  Orphan designation in ...
    Cached Medicine Technology:American Foundation for the Blind Announces 2012 Access Award Winners 2American Foundation for the Blind Announces 2012 Access Award Winners 3Ultragenyx Granted Orphan Designations in Europe for Two Lead Product Candidates, UX001 for HIBM and UX003 for MPS 7 2Ultragenyx Granted Orphan Designations in Europe for Two Lead Product Candidates, UX001 for HIBM and UX003 for MPS 7 3
    (Date:12/26/2014)... Yisrayl Hawkins, Pastor at The House of Yahweh in ... the Ferguson, Missouri unrest. Yisrayl starts his letter by showing ... it has only increased. , He continues in his ... there is a very specific reason for mankind and covers ... set of rules, or Laws that if followed would ensure ...
    (Date:12/26/2014)... Viejo, California (PRWEB) December 26, 2014 Plugin ... announced the TransPack Volume 5 Plugin for Final Cut Pro ... manipulate a hard light tool to pull off an industry ... “When users get their hands on TransPack Volume 5, a ... Volume 5 is a set of over 50 Final Cut ...
    (Date:12/26/2014)... FL (PRWEB) December 26, 2014 India ... health insurance in the USA, announced today a new ... assist members in choosing the right plan for their ... the complexity out of the selection process when choosing ... by age group with only a few clicks. Many ...
    (Date:12/26/2014)... December 26, 2014 DW-InductionHeating.com (DaWei Induction ... designing, researching and developing, producing and marketing of a ... the business announces their new series of induction ... of the company, induction brazing refers to ... special filler material and heat. The manager says that ...
    (Date:12/25/2014)... 2014 The microscopy market is ... to reach $5,756.0 million by 2019. Optical microscopy ... The electron microscopes product segment is expected to ... , Rising focus on nanotechnology, technological advancements, and ... microscopy market. , Get Full Copy of Report ...
    Breaking Medicine News(10 mins):Health News:Yisrayl Hawkins Pleads for Peace in Ferguson and Beyond in New Open Letter 2Health News:Today a new plugin was announced from Pixel Film Studios, TransPack Volume 5 for Final Cut Pro X 2Health News:India Network Health Insurance Announces new Comprehensive Pre-existing Condition Coverage policy for Visitors to the United States 2Health News:India Network Health Insurance Announces new Comprehensive Pre-existing Condition Coverage policy for Visitors to the United States 3Health News:Induction Brazing Equipment Series From DaWei Induction Heating Co., A Reliable Supplier Of Induction Heating Equipment 2Health News:Microscopy Market Hit to $5,756.0 Million by 2019 - New Research Report by MarketsandMarkets 2Health News:Microscopy Market Hit to $5,756.0 Million by 2019 - New Research Report by MarketsandMarkets 3Health News:Microscopy Market Hit to $5,756.0 Million by 2019 - New Research Report by MarketsandMarkets 4
    ... program focused on cervical cancer prevention thanks to ... Indiana University School of Medicine, in partnership with ... Cancer-Free America (CCFA) is an initiative designed to ... increase rates of human papillomavirus (HPV) vaccination with ...
    ... imaging plays an important role in biological and ... advanced technology and expertise, and can be costly. ... today, aims to provide scientists throughout Europe with ... levels of biological and biomedical research, from bench ...
    ... Harvard-affiliated McLean Hospital and the University of Utah have ... date. The test was able to detect the disorder ... The study will be published online the week of ... which uses MRI to measure deviations in brain circuitry, ...
    ... Dec. 1 (HealthDay News) - A physician with experience ... "Don,t Ask, Don,t Tell" policy puts both service members ... about sexual health issues. "Infections go undiagnosed. Service ... a physician at San Diego State University and the ...
    ... nearly three times as likely as civilians to commit ... Portland State University (PSU) and Oregon Health & Science ... Women With U.S. Military Service: A Hidden Epidemic?" appears ... , a journal published by the American Psychiatric Association. ...
    ... (HealthDay News) -- Deployment to Iraq and Afghanistan significantly ... U.S. military personnel, new research indicates. Researchers conducted ... military before they deployed to these conflict zones. The ... the journal Sleep . "This is the ...
    Cached Medicine News:Health News:Grant launches cervical cancer-free Indiana initiative 2Health News:Better imaging from bench to bedside 2Health News:University of Utah and Harvard researchers take major step toward first biological test for autism 2Health News:'Don't Ask, Don't Tell' May Put Soldiers' Health at Risk, Doctor Says 2Health News:Suicide rate among young women veterans more than twice that of civilians 2Health News:Military Deployment May Lead to Unhealthy Sleep Patterns 2
    ... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
    ... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
    ... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
    ... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
    Medicine Products: